 Regulus Therapeutics, Inc. NASDAQ:RGLS Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Crispina Calsada - CFO Joseph Hagan - President, CEO Director Conference Call Participants Yi Chen - H.C. Wainwright Co. Operator Good day, and welcome to the Regulus Therapeutics Inc. First Quarter 2022 Conference Call. 